Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Top Cited Papers
- 14 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 133 (24), 2459-2502
- https://doi.org/10.1161/circulationaha.116.022194
Abstract
Cardiovascular disease remains the principal cause of death and disability among patients with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying atherosclerosis and heart failure. Unfortunately, these mechanisms are not adequately modulated by therapeutic strategies focusing solely on optimal glycemic control with currently available drugs or approaches. In the setting of multifactorial risk reduction with statins and other lipid-lowering agents, antihypertensive therapies, and antihyperglycemic treatment strategies, cardiovascular complication rates are falling, yet remain higher for patients with diabetes mellitus than for those without. This review considers the mechanisms, history, controversies, new pharmacological agents, and recent evidence for current guidelines for cardiovascular management in the patient with diabetes mellitus to support evidence-based care in the patient with diabetes mellitus and heart disease outside of the acute care setting.Keywords
This publication has 504 references indexed in Scilit:
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular DiseaseThe American Journal of Cardiology, 2011
- Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999–2006Obesity Surgery, 2010
- Loss of Insulin Signaling in Vascular Endothelial Cells Accelerates Atherosclerosis in Apolipoprotein E Null MiceCell Metabolism, 2010
- Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetesDiabetologia, 2010
- Diabetic cardiomyopathy, causes and effectsReviews in Endocrine and Metabolic Disorders, 2010
- Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory responseJournal of Molecular Medicine, 2009
- The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysisDiabetologia, 2005
- Inflammation in atherosclerosisNature, 2002
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993